Schroder Investment Management Group Arvinas, Inc. Transaction History

Schroder Investment Management Group

$94.5 Billion
Q3 2024

A detailed history of Schroder Investment Management Group transactions in Arvinas, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 23,769 shares of ARVN stock, worth $427,842. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,769

Previous 108,444 78.08%

Holding current value

$427,842

Previous $2.89 Million 79.73%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$23.66 - $32.73 $2 Million - $2.77 Million	-84,675 Reduced 78.08%	23,769 $585,000
Q2 2024 Aug 12, 2024	BUY	$24.46 - $40.4 $2.24 Million - $3.69 Million	91,444 Added 537.91%	108,444 $2.89 Million
Q4 2023 Feb 13, 2024	BUY	$14.19 - $42.33 $241,230 - $719,610	17,000 New	17,000 $699,000
Q1 2023 May 11, 2023	SELL	$26.15 - $37.26 $704,742 - $1 Million	-26,950 Reduced 64.91%	14,566 $397,000
Q4 2022 Feb 10, 2023	SELL	$32.47 - $57.24 $858,539 - $1.51 Million	-26,441 Reduced 38.91%	41,516 $1.42 Million
Q3 2022 Nov 10, 2022	SELL	$41.87 - $57.99 $1.71 Million - $2.37 Million	-40,878 Reduced 37.56%	67,957 $3.02 Million
Q2 2022 Aug 11, 2022	SELL	$36.01 - $74.24 $671,982 - $1.39 Million	-18,661 Reduced 14.64%	108,835 $4.75 Million
Q1 2022 May 16, 2022	BUY	$60.27 - $81.57 $2.42 Million - $3.27 Million	40,104 Added 45.89%	127,496 $8.14 Million
Q4 2021 Feb 14, 2022	BUY	$65.85 - $96.21 $5.75 Million - $8.41 Million	87,392 New	87,392 $7.18 Million
Q2 2020 Aug 13, 2020	SELL	$29.88 - $56.74 $1.13 Million - $2.14 Million	-37,773 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$33.0 - $54.5 $1.11 Million - $1.83 Million	33,588 Added 802.58%	37,773 $1.61 Million
Q4 2019 Feb 11, 2020	BUY	$15.39 - $44.38 $64,407 - $185,730	4,185 New	4,185 $172,000

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $958M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Arvinas, Inc. Transaction History